Mucosal nerve deficiency in chronic childhood constipation: a postmigration defect?

Gwen Wendelschafer-Crabb1, Vishala Neppalli, Jose Jessurun

  • 1Department of Neurology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. crabb001@umn.edu

Insights

Children with idiopathic chronic childhood constipation (ICCC) often have reduced rectal mucosal nerves, indicating autonomic dysfunction. This finding helps diagnose ICCC in children without Hirschsprung

Area of Science:

  • Pediatric Gastroenterology
  • Neurogastroenterology
  • Autonomic Nervous System Research

Background:

  • Idiopathic chronic childhood constipation (ICCC) affects children resistant to standard treatments.
  • Distinguishing ICCC from Hirschsprung's disease (HSCR) relies on rectal biopsy findings.
  • Autonomic dysfunction is a potential underlying factor in ICCC.

Purpose of the Study:

  • To investigate potential autonomic dysfunction in children with ICCC.
  • To examine rectal mucosal nerves in ICCC patients.
  • To compare innervation in ICCC, HSCR, and non-constipated children.

Main Methods:

  • Rectal biopsy specimens from constipated children were analyzed.
  • Immunostaining and confocal microscopy were employed.
  • A computer-assisted neuron tracing technique quantified mucosal nerve density.

Main Results:

  • Zamboni-fixed specimens showed superior nerve staining compared to formalin-fixed.
  • Children with ICCC exhibited significantly reduced rectal mucosal nerve density.
  • Severe nerve deficiency was also noted in HSCR patients, even in ganglion-containing segments.

Conclusions:

  • Decreased rectal mucosal innervation is common in ICCC.
  • Reduced mucosal nerves may contribute to constipation by impairing reflexes and secretion.
  • Mucosal nerve density offers a diagnostic marker for ICCC, distinct from HSCR.
  • Neuron tracing validates as an objective method for assessing innervation.
Abstract

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Nerve Supply of the GI Tract01:27

Nerve Supply of the GI Tract

The neuronal supply to the gastrointestinal (GI) tract is essential for regulating various functions, including digestion, absorption, and movement of food. This intricate network of nerves is known as the enteric nervous system (ENS), often referred to as the "second brain" of the body.
The enteric nervous system consists of two major plexuses: the myenteric plexus (Auerbach's plexus) and the submucosal plexus (Meissner's plexus). These plexuses are located within the layers of the GI tract...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...